Rising burden of cancer and atrial fibrillation related mortality among adults in the United States, 1999-2019
File(s)1-s2.0-S2666501825001564-main.pdf (1.26 MB)
Published version (pre-proof)
Author(s)
Saad, Muhammad
Shaikh, Reyan Hussain
Sohail, Muhammad Umer
Waqas, Saad Ahmed
Jamshed, Mian Muinuddin
Type
Journal Article
Abstract
Background
Atrial fibrillation (AF) is the most common cardiac arrhythmia, while cancer remains the second leading cause of death in the United States. Both conditions share several risk factors and may compound mortality risk. However, national trends in AF and cancer-related mortality remain underexplored.
Objective
To assess trends in mortality related to AF and cancer among U.S. adults from 1999 to 2019, using demographic and geographic stratifications.
Methods
Data were obtained from the CDC WONDER Multiple Cause of Death dataset. We identified individuals aged 25 years and older with AF (I48) and cancer (C00-C97) as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population, average annual percentage change (AAPC) and annual percentage change (APC) were calculated.
Results
The AAMR for cancer and AF-related deaths increased from 4.95 [95% CI: 4.84, 5.05] in 1999 to 10.01 [95% CI: 9.88, 10.13] in 2019 (AAPC: 3.49 [95% CI: 3.39, 3.60]). Males had higher AAMRs than females (10.24 vs. 5.13). NH Whites had the highest AAMRs (7.56), followed by NH Blacks (4.44) and Hispanics (3.11). The Western region had the highest AAMR, and nonmetropolitan areas exhibited greater mortality rates than metropolitan areas. Individuals with lung cancer exhibited the highest AAMRs (1.65), followed by gastrointestinal cancer (1.52) and hematologic cancer (1.00). The lowest AAMRs were observed in prostate cancer (0.90) and breast cancer (0.65).
Conclusion
Mortality from cancer and AF has increased over time, with significant disparities across sex, race, and geography. Targeted interventions are required to mitigate these disparities.
Atrial fibrillation (AF) is the most common cardiac arrhythmia, while cancer remains the second leading cause of death in the United States. Both conditions share several risk factors and may compound mortality risk. However, national trends in AF and cancer-related mortality remain underexplored.
Objective
To assess trends in mortality related to AF and cancer among U.S. adults from 1999 to 2019, using demographic and geographic stratifications.
Methods
Data were obtained from the CDC WONDER Multiple Cause of Death dataset. We identified individuals aged 25 years and older with AF (I48) and cancer (C00-C97) as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population, average annual percentage change (AAPC) and annual percentage change (APC) were calculated.
Results
The AAMR for cancer and AF-related deaths increased from 4.95 [95% CI: 4.84, 5.05] in 1999 to 10.01 [95% CI: 9.88, 10.13] in 2019 (AAPC: 3.49 [95% CI: 3.39, 3.60]). Males had higher AAMRs than females (10.24 vs. 5.13). NH Whites had the highest AAMRs (7.56), followed by NH Blacks (4.44) and Hispanics (3.11). The Western region had the highest AAMR, and nonmetropolitan areas exhibited greater mortality rates than metropolitan areas. Individuals with lung cancer exhibited the highest AAMRs (1.65), followed by gastrointestinal cancer (1.52) and hematologic cancer (1.00). The lowest AAMRs were observed in prostate cancer (0.90) and breast cancer (0.65).
Conclusion
Mortality from cancer and AF has increased over time, with significant disparities across sex, race, and geography. Targeted interventions are required to mitigate these disparities.
Date Issued
2025-05-13
Date Acceptance
2025-05-07
Citation
Heart Rhythm O2, 2025
ISSN
2666-5018
Publisher
Elsevier
Journal / Book Title
Heart Rhythm O2
Copyright Statement
© 2025 Heart Rhythm Society. Published by Elsevier Inc.
License URL
Identifier
10.1016/j.hroo.2025.05.006
Publication Status
Published online
Date Publish Online
2025-05-13